UPDATED Mar 15, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ABI | €55.39 | -2.2% | -1.6% | €109.1b | €65.14 | PE22.2x | E13.6% | 1.5% | Food, Beverage & Tobacco | ||
KBC | €69.04 | 1.7% | 17.3% | €27.9b | €72.24 | PB1.2x | E-2.4% | 6.0% | Banks | ||
UCB | €104.40 | -5.0% | 33.1% | €19.8b | €114.28 | PE57.8x | E25.9% | 1.3% | Pharmaceuticals & Biotech |